Risk categories and refractory CLL in the era of chemoimmunotherapy

Standardized criteria for diagnosis and response evaluation in chronic lymphocytic leukemia (CLL) are essential to achieve comparability of results and improvement of clinical care. With the increasing range of therapeutic options, the treatment context is important when defining refractory CLL. Ref...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood
Päätekijät: Zenz, Thorsten, Gribben, John G., Hallek, Michael, Döhner, Hartmut, Keating, Michael J., Stilgenbauer, Stephan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2012
Aiheet:
Perspectives
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968336/
https://ncbi.nlm.nih.gov/pubmed/22394601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-11-312421
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia